AngioDynamics to Present at 32nd Annual J.P. Morgan Healthcare Conference
ALBANY, N.Y., Dec. 18, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a
leading provider of innovative, minimally invasive medical devices for
vascular access, surgery, peripheral vascular disease and oncology, is
scheduled to present at the 32^nd Annual J.P. Morgan Conference at the Westin
St. Francis Hotel in San Francisco, Calif. AngioDynamics' presentation will
take place at 3:30 p.m. Pacific Time, Wednesday, January 15, 2014. Joseph
DeVivo, President and Chief Executive Officer, will review the Company's
business strategy and recent corporate developments.
A live webcast and subsequent archived replay of AngioDynamics' Q&A session
may be accessed via the investor relations section of the Company's website
under "Events & Presentations" at
http://investors.angiodynamics.com/events.cfm. The replay will be available
for 90 days after the event.
AngioDynamics Inc. is a leading provider of innovative, minimally invasive
medical devices used by professional healthcare providers for vascular access,
surgery, peripheral vascular disease and oncology. AngioDynamics' diverse
product lines include market-leading ablation systems, fluid management
systems, vascular access products, angiographic products and accessories,
angioplasty products, drainage products, thrombolytic products and venous
products. More information is available at www.AngioDynamics.com.
AngioDynamics and the AngioDynamics logo are trademarks and/or registered
trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
CONTACT: Company Contact:
Mark Frost, CFO
(800) 772-6446 x1981
Investor Relations Contacts:
EVC Group, Inc.
Michael Polyviou/Robert Jones
(212) 850-6020; (646) 201-5447
EVC Group, Inc.
Press spacebar to pause and continue. Press esc to stop.